On July 22, 2016, President Obama signed the Comprehensive Addiction and Recovery Act (CARA) in to law.
CARA authorizes qualified nurse practitioners (NPs) and physician assistants (PAs) to become waivered to prescribe buprenorphine in office‐based settings for patients with opioid use disorder (OUD) for a five‐year period expiring in October 2021.
To qualify, NPs and PAs must:
AANP was listed in the law as one of the organizations that is qualified to provide the necessary education. AANP collaborated with the American Society of Addiction Medicine (ASAM) and the American Academy of PAs (AAPA) to provide the required 24 hours of education. You can register for the courses in the AANP CE Center. By going through the AANP CE Center, you ensure that your CE certificate and a list of the completed courses will always be available in your portfolio. Additionally, AANP has accredited several programs suitable for the mandatory 24 hours of CE credit, which includes 18 hours of pharmacology credit. For questions related to education, please email CECenter@aanp.org.
*NOTE: CARA also defers to state law regarding whether an NP or PA works with a physician through a supervisory or collaborative relationship and, where this applies, the physician must also be qualified to prescribe buprenorphine.